These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15710101)

  • 1. [Multiple endocrine neoplasia 2A type: a genetic study of one family].
    Arias Miranda IM; Casal Alvarez F; Castaño L
    Med Clin (Barc); 2005 Jan; 124(3):116. PubMed ID: 15710101
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic thyroidectomy in MEN 2A syndrome.
    Mattavelli F; Seregni E; Collini P; Pasini B; Aiello A; Barbaccia C; Bimbi G; Riccio S; Santamaria S
    Tumori; 2003; 89(5):553-5. PubMed ID: 14870785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 2.
    Forster-Gibson CJ; Mulligan LM
    Eur J Cancer; 1994; 30A(13):1969-74. PubMed ID: 7734209
    [No Abstract]   [Full Text] [Related]  

  • 4. The familial medullary thyroid carcinoma-associated RET E768D mutation in a multiple endocrine neoplasia type 2A case.
    Aiello A; Cioni K; Gobbo M; Collini P; Gullo M; Della Torre G; Passerini E; Ferrando B; Pilotti S; Pierotti MA; Pasini B
    Surgery; 2005 May; 137(5):574-6. PubMed ID: 15855933
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple endocrine neoplasia type 2A in Chinese families.
    Lo CY; Wat NM; Lam KY; Tiu SC; Chan J; Lam KS
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):528. PubMed ID: 12641638
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A.
    Skinner MA; Moley JA; Dilley WG; Owzar K; Debenedetti MK; Wells SA
    N Engl J Med; 2005 Sep; 353(11):1105-13. PubMed ID: 16162881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost analysis of DNA-based testing in a large Canadian family with multiple endocrine neoplasia type 2.
    Gilchrist DM; Morrish DW; Bridge PJ; Brown JL
    Clin Genet; 2004 Oct; 66(4):349-52. PubMed ID: 15355438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medullary cancers of the thyroid: genetic aspects].
    Orgiazzi J
    Ann Endocrinol (Paris); 2003 Oct; 64(4):345-9. PubMed ID: 14595251
    [No Abstract]   [Full Text] [Related]  

  • 10. [RET mutations and preventive treatment of medullary thyroid cancer].
    Niccoli-Sire P; Conte-Devolx B;
    Ann Endocrinol (Paris); 2005 Jun; 66(3):168-75. PubMed ID: 15988377
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prophylactic total thyroidectomy in children and adolescents with genetic mutations in the RET-protooncogene].
    Spinelli C; Puccini M; Bertocchini A; Lima M; Pacini F; Miccoli P
    Pediatr Med Chir; 2002; 24(1):53-7. PubMed ID: 11938683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RET IVS1-126G>T variant is strongly associated with the development of sporadic medullary thyroid cancer.
    Fernandez RM; Robledo M; Antinolo G; Pecina A; Ruiz-Llorente S; Eng C; Borrego S
    Thyroid; 2004 Apr; 14(4):329-31. PubMed ID: 15142370
    [No Abstract]   [Full Text] [Related]  

  • 13. Germline RET V804M mutation associated with multiple endocrine neoplasia type 2A.
    Gibelin H; Bezieau S; Misso C; Bouin-Pineau MH; Maréchaud R; Kraimps JL
    Br J Surg; 2004 Nov; 91(11):1458-9. PubMed ID: 15386323
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.
    Wells SA; Chi DD; Toshima K; Dehner LP; Coffin CM; Dowton SB; Ivanovich JL; DeBenedetti MK; Dilley WG; Moley JF
    Ann Surg; 1994 Sep; 220(3):237-47; discussion 247-50. PubMed ID: 7916559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Description of the first two seemingly unrelated Greek Cypriot families with a common C618R RET proto-oncogene mutation.
    Neocleous V; Passalaris T; Spanou E; Kitsios P; Skordis N; Deltas CC
    Genet Test; 2004; 8(2):163-8. PubMed ID: 15345114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
    Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
    Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease.
    Sasaki Y; Shimotake T; Go S; Iwai N
    Eur J Surg; 2001 Jun; 167(6):467-9. PubMed ID: 11471675
    [No Abstract]   [Full Text] [Related]  

  • 18. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive DNA testing for multiple endocrine neoplasia 2: a therapeutic challenge of prophylactic thyroidectomy in very young children.
    van Heurn LW; Schaap C; Sie G; Haagen AA; Gerver WJ; Freling G; van Amstel HK; Heineman E
    J Pediatr Surg; 1999 Apr; 34(4):568-71. PubMed ID: 10235324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learned from the management of a rare genetic cancer.
    Cote GJ; Gagel RF
    N Engl J Med; 2003 Oct; 349(16):1566-8. PubMed ID: 14561800
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.